Clinical Practice Guidelines for the Medical Management of Nonhospitalized Ulcerative Colitis: The Toronto ConsensusBrian Bressler, Chadwick Williams, John K. Marshall et al.|Gastroenterology|2015Cited by 413
Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel DiseasesKonstantinos Papamichael, Corey A. Siegel, Laura E. Raffals et al.|Clinical Gastroenterology and Hepatology|2019Cited by 336
Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti–Tumor Necrosis Factor Therapy for Crohn’s Disease: A Meta-analysis of Placebo-controlled TrialsJennifer Jones, Corey A. Siegel, Gilaad G. Kaplan et al.|Clinical Gastroenterology and Hepatology|2015Cited by 121
Defining Quality Indicators for Best-Practice Management of Inflammatory Bowel Disease in CanadaGeoffrey C. Nguyen, Jennifer Jones, Shane Devlin et al.|Canadian Journal of Gastroenterology and Hepatology|2014Cited by 57
The Appropriateness of Concomitant Immunomodulators With Anti–Tumor Necrosis Factor Agents for Crohn's Disease: One Size Does Not Fit AllGil Melmed, Corey A. Siegel, Brennan Spiegel et al.|Clinical Gastroenterology and Hepatology|2010Cited by 50